TY - JOUR
T1 - Empfehlungen für ECMO bei COVID-19-Patienten
T2 - Consensus Paper zur Extrakorporalen Membranoxygenierung der Medizinischen Universität Wien
AU - COVID-19 ECMO Arbeitsgruppe Medizinische Universität Wien
AU - Wiedemann, Dominik
AU - Bernardi, Martin H
AU - Distelmaier, Klaus
AU - Goliasch, Georg
AU - Hengstenberg, Christian
AU - Hermann, Alexander
AU - Holzer, Michael
AU - Hoetzenecker, Konrad
AU - Klepetko, Walter
AU - Lang, György
AU - Lassnigg, Andrea
AU - Laufer, Günther
AU - Magnet, Ingrid A M
AU - Markstaller, Klaus
AU - Röggla, Martin
AU - Rössler, Bernhard
AU - Schellongowski, Peter
AU - Simon, Paul
AU - Tschernko, Edda
AU - Ullrich, Roman
AU - Zimpfer, Daniel
AU - Staudinger, Thomas
N1 - © The Author(s) 2020.
PY - 2020
Y1 - 2020
N2 - The pandemic from the SARS-CoV‑2 Virus is currently challenging health care systems all over the world. Maintaining appropriate staffing and resources in healthcare facilities is essential to guarantee a safe work environment for healthcare personnel and safe patient care. Extracorporeal membrane oxygenation (ECMO) represents a valuable therapeutic option in patients with severe heart or lung failure. Although only a limited proportion of COVID-19 patients develops respiratory or circulatory failure that is refractory to conventional therapies, it is of utmost importance to clearly define criteria for the use of ECMOs in this steadily growing patient population. The ECMO working group of the Medical University of Vienna has established the following recommendations for ECMO support in COVID-19 patients.
AB - The pandemic from the SARS-CoV‑2 Virus is currently challenging health care systems all over the world. Maintaining appropriate staffing and resources in healthcare facilities is essential to guarantee a safe work environment for healthcare personnel and safe patient care. Extracorporeal membrane oxygenation (ECMO) represents a valuable therapeutic option in patients with severe heart or lung failure. Although only a limited proportion of COVID-19 patients develops respiratory or circulatory failure that is refractory to conventional therapies, it is of utmost importance to clearly define criteria for the use of ECMOs in this steadily growing patient population. The ECMO working group of the Medical University of Vienna has established the following recommendations for ECMO support in COVID-19 patients.
U2 - 10.1007/s00740-020-00349-x
DO - 10.1007/s00740-020-00349-x
M3 - Übersichtsartikel
C2 - 32837601
SN - 1869-1757
VL - 23
SP - 168
EP - 173
JO - Wiener klinisches Magazin
JF - Wiener klinisches Magazin
IS - 4
ER -
